Business Description
Aptevo Therapeutics is a Seattle-based biotechnology company focused on developing new treatments for cancer by harnessing the body's own immune system. Founded in 2016, the company uses its proprietary platforms to create a range of antibody-based therapies targeting blood cancers and solid tumors. Its most advanced treatment candidate is currently in mid-stage clinical trials for acute myelogenous leukemia, while several other candidates are being tested or studied across a wide variety of cancer types. The company also works with external partners to advance select programs through the development pipeline.
